Therapeutic Advances in Respiratory Disease Q1 Unclaimed
Therapeutic Advances in Respiratory Disease is a journal indexed in SJR in Pulmonary and Respiratory Medicine and Pharmacology (medical) with an H index of 46. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on respiratory diseases, respiratory disorders, respiratory medicine. It has an SJR impact factor of 1,092 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,092.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1800 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,092
SJR Impact factor46
H Index66
Total Docs (Last Year)200
Total Docs (3 years)3170
Total Refs793
Total Cites (3 years)189
Citable Docs (3 years)4.11
Cites/Doc (2 years)48.03
Ref/DocOther journals with similar parameters
American Journal of Respiratory and Critical Care Medicine Q1
Journal of Thoracic Oncology Q1
European Respiratory Journal Q1
Thorax Q1
Sleep Medicine Reviews Q1
Compare this journals
Aims and Scope
Best articles by citations
The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting
View moreRespiratory failure, lung infiltrates, and hemoptysis in a woman with chronic isopropyl alcohol inhalation
View moreModifiable risk factors associated with bronchiolitis
View moreReview: Safety of long-acting beta2 -agonists in the treatment of asthma
View morePulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease
View morePolymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease
View moreIntrapleural hemorrhage after administration of tPA: a case report and review of the literature
View moreAre nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring
View moreClinical assessment of the obstructive sleep apnoea/hypopnoea syndrome
View moreAlpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis
View moreCharacterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study
View moreA new horizon in the treatment of biofilm-associated tonsillitis
View moreMIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece
View moreThe impact of psychological distress on exacerbation rates in COPD
View moreNew treatment options for bronchiectasis
View moreReview: Systemic consequences of COPD
View moreThe benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease
View moreDiagnostic yield and safety of sputum induction with nebulized racemic salbutamol versus hypertonic saline in smear-negative pulmonary tuberculosis
View morePatient and provider perceptions of sleep disordered breathing assessment during prenatal care: a survey-based observational study
View moreClinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
View moreAntifungal medication is efficient in the treatment of sarcoidosis
View moreMatrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency
View morePharmacotherapy of asthma: regular treatment or on demand?
View moreStorage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patients
View more
Comments